However, this ratio is increased in most triple negative breast cancer cells (Smad3/Smad2 > 1.0; Figure 1A) except for MDA-MB-453 cell line (Smad3/Smad2 = 0.1; Figure 1A). The gene discussed is SMAD2; the disease is triple-negative breast carcinoma.